
Amicus Therapeutics FOLD
$ 14.39
0.1%
Annual report 2025
added 02-20-2026
Amicus Therapeutics Long Term Debt Current 2011-2026 | FOLD
Annual Long Term Debt Current Amicus Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.74 M | 8.46 M | 8.32 M | 8.55 M | 7.41 M | 6.87 M | 7.19 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.74 M | 6.87 M | 7.93 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.55 | -0.42 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
1.03 M | $ 3.24 | 3.35 % | $ 229 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | ||
|
ADC Therapeutics SA
ADCT
|
1.1 M | $ 4.14 | -1.9 % | $ 105 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.82 | 4.22 % | $ 4.47 M | ||
|
argenx SE
ARGX
|
6.53 M | $ 714.55 | 1.6 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
14.2 M | $ 231.26 | 0.1 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.4 | -5.82 % | $ 8.18 B | ||
|
Atea Pharmaceuticals
AVIR
|
843 K | $ 6.09 | 0.66 % | $ 496 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 6.6 | -0.45 % | $ 181 M | ||
|
BioCardia
BCDA
|
333 K | $ 1.37 | 7.87 % | $ 29 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Catalyst Biosciences
CBIO
|
636 K | $ 11.29 | -2.5 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
1.6 M | $ 14.61 | 1.71 % | $ 214 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 92.9 | 2.61 % | $ 27.2 B | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.64 | - | $ 16.6 M | ||
|
CorMedix
CRMD
|
853 K | $ 6.57 | 0.46 % | $ 473 K | ||
|
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.5 | -0.99 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M |